HP is a 24 y/o male that presents to your clinic with 2 to 3 lesions of mild impetigo. What is the most effective treatment for HP?

Impetigo is a highly contagious superficial bacterial skin infection commonly caused by Staphylococcus aureus and sometimes Streptococcus pyogenes. It typically presents as honey-colored crusted lesions and is most often managed with topical or systemic antibiotics depending on severity and extent. Localized, mild cases are best treated with topical agents to limit systemic exposure and effectively eradicate the infection. Early treatment also helps prevent spread to others and further skin involvement. Rationale: A. Miconazole (Lotrimin) is an antifungal agent used to treat fungal infections such as tinea corporis or candidiasis. Since impetigo is a bacterial infection, miconazole has no activity against Staphylococcus aureus or Streptococcus pyogenes. Using an antifungal would not resolve the infection and could allow progression or spread. B. Mupirocin (Bactroban) is the first-line treatment for mild, localized impetigo. It works by inhibiting bacterial protein synthesis, effectively targeting common causative organisms such as Staphylococcus aureus. For limited lesions, topical therapy is preferred because it is highly effective, reduces systemic side effects, and directly treats the infected skin area. C. Amoxicillin-clavulanate (Augmentin) is an oral antibiotic reserved for more extensive, severe, or systemic infections. While it has activity against common impetigo pathogens, it is not necessary for mild localized lesions. Oral therapy increases systemic exposure and is typically avoided when topical treatment is sufficient. D. Cephalexin (Keflex) is effective against many gram-positive organisms and may be used for more widespread impetigo. However, for 2–3 localized lesions, systemic therapy is not indicated as first-line management. Topical treatment is equally effective in mild cases and minimizes unnecessary antibiotic exposure.